CHRISTOPHER TIPTON: Open Payments
NPI 1750363685 · MAN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 15 payments from 9 companies in 2025. Trend: 2023 $566 · 2024 $358 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $90 |
| Novo Nordisk Inc | 3 | $55 |
| Tactile Systems Technology Inc | 1 | $48 |
| Amgen Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Abbott Laboratories | 1 | $10 |
Products named: QULIPTA, Flexitouch Plus, Ozempic, FASENRA, Rybelsus, REPATHA, ARALAST, OTEZLA.
Industry payments across WV — which companies pay providers there.
